Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CBER
Fierce Pharma
FDA investigates 2 deaths after Sarepta Duchenne gene therapy
The agency is investigating two Duchenne muscular dystrophy patient deaths following treatment with Sarepta Therapeutics’ Elevidys.
Angus Liu
Jun 25, 2025 10:26am
Fierce Pharma
FDA's acting CDER head heads for the exit: report
Jun 23, 2025 1:48pm
BMS banks on Wall Street vet for strategy— Chutes & Ladders
Jun 20, 2025 8:30am
FDA hopes AI can deliver 'rapid or instant' reviews
Jun 11, 2025 12:45pm
At cell and gene roundtable, officials pledge to slash regulations
Jun 5, 2025 2:50pm
FDA leadership 'decapitated,' former leader Janet Woodcock says
Apr 7, 2025 4:04pm